POLYMEDNSEPoly Medicure Limited· PharmaceuticalsMinimalNeutral
Announced Mon, 11 Aug · 16:50 IST

Poly Medicure Limited has informed the Exchange about Copy of Newspaper Publication

POLYMED · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Poly Medicure Limited has submitted to the exchanges copies of newspaper advertisements containing its unaudited financial results for the quarter ended June 30, 2025, originally published in Financial Express and Jansatta on August 9, 2025. On a standalone basis, total income from operations rose to Rs 42,514.22 lakhs (up from Rs 38,425.62 lakhs in Q1 FY25), while net profit after tax grew to Rs 8,792.89 lakhs (up from Rs 7,230.25 lakhs), translating to a basic EPS of Rs 8.68 (vs Rs 7.53). On a consolidated basis, total income stood at Rs 44,490.16 lakhs with net profit after tax at Rs 9,308.29 lakhs and basic EPS of Rs 9.19. The results were approved by the Board on August 8, 2025, after review by the Audit Committee and limited review by statutory auditors.

Likely market impact

This is a routine regulatory filing sharing the newspaper version of results already disclosed — no new information for shareholders, but it confirms strong double-digit year-on-year growth in both revenue and profit, which is mildly positive for sentiment.